Mouse PD-1 Standard (小鼠程序性死亡受体1 (PD-1) 标准品) 组分 小鼠PD-1冻干标准品 检测方法 双抗夹心法 样本类型 血清,血浆,细胞培养上清及其他生物学样本 板式 管 保存 短期4℃,长期-20℃保存 运输条件 4℃蓝冰运输 检测原理:本试剂盒采用双抗体夹心酶联免疫吸附检测技术。特异性抗小鼠PD-1抗体预包被...
The target protein is expressed with sequence (Leu25-Gln167) of mouse PD-1 (Accession #NP_032824.1) fused with a 6×His tag at the C-terminus. 靶点背景信息 基因ID 18566 Swiss Prot Q02242 别名 CD279;mPD-1;SLEB2;PDCD1;PD1 瑾萱生物的重组蛋白表达和纯化及定制生产服务包括:重组蛋白大肠杆菌...
中文名称:Recombinant Mouse PD-1/PDCD1(Fc fusion) 英文名称:Recombinant Mouse PD-1/PDCD1(Fc fusion) Derived from: Human cells Endotoxin: Less than 0.1 ng/ug (1 IEU/ug) as determined by LAL test. Formulation: Lyophilized from a 0.2 μm filtered solution of 20mM Tris,150mM NaCl,pH8.0. ...
The rat anti-mouse PD-1 monoclonal antibody (大鼠抗小鼠PD-1单克隆抗体)(clone No. RMP1-14, rat IgG2a kappa)reacts with the mouse PD-1 protein (CD279 or programmed death-1) encoded by the mouse pdcd1 gene, a member of the CD28 family of the Ig superfamily. PD-1 has two ligands, ...
Mouse PD-1 ELISA Kit (小鼠程序性死亡受体1 (PD-1) ELISA试剂盒) 检测方法 双抗夹心法 精密度 板内变异系数:1.9% - 2.3%;板间变异系数:2.6% - 3.0% 样本类型 血清,血浆,细胞培养上清及其他生物学样本 检测样本体积 80 μL 1×检测缓冲液和20 μL样本 ...
Anti-Mouse PD-1(RMP1-14) 价格￥1500 起批量≥1支 最小起订1支 供货总量100支 发货地址湖北省武汉市 建议售价￥1500/支 更新日期2025年03月12日 产品规格1mg 即时洽谈立即询价查看联系方式 收藏产品发送留言 VIP6年 武汉科斯坦生物科技有限公司
Mouse PD-1 ELISA Kit 沪震生物的Mouse PD-1 ELISA Kit (Mouse Programmed Death-1 receptor Enzyme-Linked ImmunoSorbent Assay Kit),即小鼠程序性死亡分子1酶联免疫吸附检测试剂盒,是一种用于特异性地高灵敏地定量检测小鼠血清、血浆或细胞培养上清液中的PD-1的ELISA试剂盒。本产品检测灵敏度高,特异性强,重复性...
Anti-Mouse PD-1 抗体 (RMP1-14) 英文名称: Anti-Mouse PD-1 Antibody (RMP1-14) 总访问: 45 国产/进口: 进口 半年访问: 19 产地/品牌: MedChemExpress(MCE) 产品类别: 生化试剂 规格: 1 mg; 5 mg; 10 mg; 25 mg 最后更新: 2024-4-30 货号: HY-P99144 CAS 号: 参考报价: 850; 2900;...
interaction between PD-L1 and its receptor PD-1. For these reasons anti-PD-1 mediated immunotherapies are currently being explored as cancer treatments. Like the J43 antibody the RMP1-14 antibody has been shown to block the binding of both mouse PD-L1-Ig and mouse PD-L2-Ig to PD-1....
interaction between PD-L1 and its receptor PD-1. For these reasons anti-PD-1 mediated immunotherapies are currently being explored as cancer treatments. Like the J43 antibody the RMP1-14 antibody has been shown to block the binding of both mouse PD-L1-Ig and mouse PD-L2-Ig to PD-1. ...